ArticleEClinicalMedicine2023

The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis.

Luca Mastrantoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.